Lista de obras - Monika Białecka - Dominio Público Uruguay

Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis

artículo científico publicado en 2010

Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease

scientific article published on 01 December 2005

Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

artículo científico publicado en 2004

Association between CRP gene polymorphism 717A/G, C-reactive protein and neurological deficit in ischemic stroke.

artículo científico publicado en 2013

Association of COMT gene variability with pain intensity in patients after total hip replacement

scientific article published on 01 March 2019

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease

artículo científico publicado en 2012

Association of catechol-O-methyltransferase gene variability with pain sensitivity in patients after hip replacement

artículo científico publicado en 2015

Association study of GATA-2 transcription factor gene (GATA2) polymorphism and Parkinson's disease.

artículo científico publicado en 2009

BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease

artículo científico publicado en 2014

CARD15 variants in patients with sporadic Parkinson's disease

artículo científico publicado en 2007

Can we talk about CD4+CD28- lymphocytes as a risk factor for ischemic stroke?

artículo científico publicado en 2007

Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.

artículo científico publicado en 2005

Catechol-oxide-methyltransferase (COMT rs4680:G>A) gene polymorphism does not affect analgesics’ demand after elective hip replacement

artículo científico publicado en 2016

Dopamine agonists--pharmacological similarities and differences

artículo científico publicado en 2007

Effect of interleukin 6 -174G>C gene polymorphism on opioid requirements after total hip replacement.

artículo científico publicado en 2016

Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits

artículo científico publicado en 2005

Effects of common functional MMP12 gene polymorphisms on PD in a Polish population.

artículo científico publicado en 2017

Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease.

artículo científico publicado en 2009

IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment

artículo científico publicado en 2018

IL17A and IL17F Gene Polymorphism Association with Psoriasis Risk and Response to Treatment in a Polish Population

artículo científico publicado en 2016

IL6 −174G>C gene polymorphism in psoriasis: Focus on treatment efficacy

artículo científico publicado en 2015

IL6−174G>C polymorphism is associated with an increased risk of psoriasis but not response to treatment

artículo científico publicado en 2015

Influence of variation in the catechol-O-methyltransferase gene on the clinical outcome after lumbar spine surgery for one-level symptomatic disc disease: a report on 176 cases

artículo científico publicado en 2013

Interleukin-10 (IL10) and tumor necrosis factor α (TNF) gene polymorphisms in Parkinson's disease patients

artículo científico publicado en 2008

Interleukin-10 Gene Polymorphism in Parkinson's Disease Patients

artículo científico publicado en 2007

Mitochondrial transcription factor A variants and the risk of Parkinson's disease

artículo científico publicado en 2010

Molecular and neuronal mechanisms of drug addiction

artículo científico publicado en 2007

N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population

artículo científico publicado en 2002

Optimisation of treatment of Parkinson's disease with levodopa

artículo científico publicado en 2009

Pain perception and cardiovascular system response among athletes playing contact sports.

artículo científico publicado en 2017

Pharmacogenetic considerations in the treatment of Parkinson's disease

artículo científico publicado en 2015

Pharmacogenetics of Parkinson's disease - through mechanisms of drug actions.

artículo científico publicado en 2013

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.

artículo científico publicado en 2010

Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection

artículo científico publicado en 2014

Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk

article

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.

artículo científico publicado en 2005

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population

artículo científico publicado en 2007

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease

artículo científico publicado en 2003

Risk factors of stroke and -717A>G (rs2794521) CRP gene polymorphism among stroke patients in West Pomerania province of Poland.

artículo científico publicado en 2014

TNF-α concentrations in pre-operative synovial fluid for predicting early post-operative function and pain after fast-track total knee arthroplasty.

artículo científico publicado en 2016

Temperament as a modulating factor of pain sensitivity in combat sport athletes

artículo científico publicado en 2017

The G allele of MMP12 -82 A > G promoter polymorphism as a protective factor for COPD in Bulgarian population.

artículo científico publicado en 2017

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications

artículo científico publicado en 2008

The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy

artículo científico publicado en 2005

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease

artículo científico publicado en 2004

The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson's disease

artículo científico publicado en 2018

The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors

artículo científico publicado en 2012

The role of estrogens in Parkinson's disease

artículo científico publicado en 2009

[Evaluation of individual vulnerability to HIV infection of health care employees--hope or reality?]

artículo científico publicado en 2006

[Pharmacogenetics in Parkinson's disease treatment]

scientific article published on 01 March 2008

[Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease]

artículo científico publicado en 2002

[The use of bisphosphonates for treating pathological states in orthopedics]

artículo científico publicado en 2008

Lista de obras de Monika Białecka

Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis

Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease

Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

Association between CRP gene polymorphism 717A/G, C-reactive protein and neurological deficit in ischemic stroke.

Association of COMT gene variability with pain intensity in patients after total hip replacement

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease

Association of catechol-O-methyltransferase gene variability with pain sensitivity in patients after hip replacement

Association study of GATA-2 transcription factor gene (GATA2) polymorphism and Parkinson's disease.

BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease

CARD15 variants in patients with sporadic Parkinson's disease

Can we talk about CD4+CD28- lymphocytes as a risk factor for ischemic stroke?

Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.

Catechol-oxide-methyltransferase (COMT rs4680:G>A) gene polymorphism does not affect analgesics’ demand after elective hip replacement

Dopamine agonists--pharmacological similarities and differences

Effect of interleukin 6 -174G>C gene polymorphism on opioid requirements after total hip replacement.

Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits

Effects of common functional MMP12 gene polymorphisms on PD in a Polish population.

Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease.

IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment

IL17A and IL17F Gene Polymorphism Association with Psoriasis Risk and Response to Treatment in a Polish Population

IL6 −174G>C gene polymorphism in psoriasis: Focus on treatment efficacy

IL6−174G>C polymorphism is associated with an increased risk of psoriasis but not response to treatment

Influence of variation in the catechol-O-methyltransferase gene on the clinical outcome after lumbar spine surgery for one-level symptomatic disc disease: a report on 176 cases

Interleukin-10 (IL10) and tumor necrosis factor α (TNF) gene polymorphisms in Parkinson's disease patients

Interleukin-10 Gene Polymorphism in Parkinson's Disease Patients

Mitochondrial transcription factor A variants and the risk of Parkinson's disease

Molecular and neuronal mechanisms of drug addiction

N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population

Optimisation of treatment of Parkinson's disease with levodopa

Pain perception and cardiovascular system response among athletes playing contact sports.

Pharmacogenetic considerations in the treatment of Parkinson's disease

Pharmacogenetics of Parkinson's disease - through mechanisms of drug actions.

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.

Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection

Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease

Risk factors of stroke and -717A>G (rs2794521) CRP gene polymorphism among stroke patients in West Pomerania province of Poland.

TNF-α concentrations in pre-operative synovial fluid for predicting early post-operative function and pain after fast-track total knee arthroplasty.

Temperament as a modulating factor of pain sensitivity in combat sport athletes

The G allele of MMP12 -82 A > G promoter polymorphism as a protective factor for COPD in Bulgarian population.

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications

The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease

The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson's disease

The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors

The role of estrogens in Parkinson's disease

[Evaluation of individual vulnerability to HIV infection of health care employees--hope or reality?]

[Pharmacogenetics in Parkinson's disease treatment]

[Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT2) in pathogenesis of Parkinson's disease]

[The use of bisphosphonates for treating pathological states in orthopedics]